Company intelligence / Profile preview

UgenTec

Hasselt, Brussels Capital Region, Belgiumugentec.com ↗

Ownership: Private
Employees: ~13
Development stage: Commercial

Overview

UgenTec’s FastFinder platform has a global installed base in over 100 molecular labs. It automates sample flow orchestration and result calling/QC for PCR/molecular diagnostic workflows. The company’s software enables standardized high-throughput data analysis with real-time QC dashboards. UgenTec was acquired by Velsera in August 2024 but continues to operate its core business as part of the integrated group focused on multiomics insights and precision medicine.

Industry: Digital Health Medical Devices

Partnerships

Roche FLOWHvidovre HospitalSeroSepSpeeDx

Beyond the preview

Go deeper on UgenTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UgenTec.

Explore the full profile